FIRST REAL-WORLD HEMATOLOGIC ADVERSE EVENTS EXPERIENCE WITH NIRAPARIB IN ADVANCED OVARIAN CANCER

被引：0
|
作者：
Wang, Junjian [1 ]
Zhu, Jianqing [1 ]
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-ESGO.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
418
引用
收藏
页码：A79 / A80
页数：2
相关论文
共 50 条
  • [1] Real-world hematological adverse events in Chinese patients with advanced ovarian cancer treated with an individualized starting dose of niraparib
    Wang, Junjian
    Zhu, Jianqing
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
  • [2] Real-world experience with a first-line niraparib maintenance monotherapy for advanced ovarian carcinoma
    Gregoric, Brigita
    Skof, Erik
    Skrbinc, Breda
    Geltar, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A220 - A220
  • [3] Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study
    Gallagher, Jack R.
    Heap, Kylee Jean
    Carroll, Susan
    Travers, Karin
    Harrow, Brooke
    Westin, Shannon N.
    FUTURE ONCOLOGY, 2019, 15 (36) : 4197 - 4206
  • [4] Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.
    Vasudevan, Anupama
    English, Sandy
    Gart, Mike
    Oladipo, Taofikat
    Hartman, John
    Iadeluca, Laura L.
    Kudrik, Fred J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Real-world Experience of Niraparib in Newly-diagnosed Epithelial Ovarian Cancer
    Shin, Wonkyo
    Noh, Joseph J.
    Baek, Seung Hun
    Kim, Byoung-Gie
    Lim, Myong Cheol
    Park, Sang-Yoon
    ANTICANCER RESEARCH, 2021, 41 (09) : 4603 - 4607
  • [6] Real-world experience of niraparib as maintenance therapy in newly diagnosed advanced ovarian cancer: A singlecenter retrospective study
    Wenxin, L.
    Wang, K.
    Zhang, L.
    Ma, Y.
    Wu, H.
    Chen, Y.
    Bao, L.
    Fu, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S1594 - S1594
  • [7] Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada
    Guan, Qi
    Aktar, Suriya J.
    Pataky, Reka E.
    Stephen, Mariet Mathew
    Marques, Maud
    Gambaro, Karen
    Rachedi, Kahina
    Forster, Katharina
    Strub, Samara
    Stock, David
    de Leseleuc, Louis
    Cheung, Winson Y.
    Peacock, Stuart
    Farrer, Christie
    Gavura, Scott
    Tadrous, Mina
    Grant, Robert C.
    Chan, Kelvin K. W.
    CURRENT ONCOLOGY, 2024, 31 (06) : 3591 - 3602
  • [8] How to start niraparib in real-world Asian ovarian cancer patients?
    Hong, Sook-Hee
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02)
  • [9] Real-world treatment of niraparib as maintenance therapy in patients newly diagnosed advanced ovarian cancer in Japan
    Shimada, Muneaki
    Kuwahara, Yuki
    Kuwabara, Hiroyo
    Kato, Ai
    Tabata, Tsutomu
    ANNALS OF ONCOLOGY, 2023, 34 : S1440 - S1440
  • [10] Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer
    Salani, Ritu
    Boyle, Tirza Areli Calderon
    Lim, Jonathan
    Schilder, Jeanne M.
    Hurteau, Jean A.
    Perhanidis, Jessica
    Golembesky, Amanda
    Backes, Floor J.
    FUTURE ONCOLOGY, 2025, 21 (02) : 213 - 219
12345